Drug Discovery

share

Luc Therapeutics has signed a license and collaboration agreement with Novartis to accelerate development of its program for...

share

Pharmalink has raised SEK100m (€10.5m) to advance the development of Nefecon as a new treatment for kidney disease....

share

Genzyme has joined in Alnylam Pharmaceuticals' investigational ALN-AT3 hemophilia program for development and commercialization in territories outside of...

share

Immuno-oncology firm Neon Therapeutics has secured $55m in initial funding to develop neoantigen-based cancer immunotherapies. Third Rock Ventures...

share

The European Medicines Agency (EMA) has released a draft guideline for public consultation on the use of pharmacokinetics...

share

Japanese firms PeptiDream and Teijin Pharma have signed a multi-target discovery and optimization collaboration agreement. As per the...

share

MRC Technology and the University of Lausanne are collaborating to find new drug treatments for diffuse large B...

share

Replimune has closed a $30m Series A financing led by Atlas Venture (Atlas). Atlas joins previous seed investors...